Obesity is a condition of being very fat and overweight. Anti-obesity therapeutics are referred as the treatment that reduces and control the body weight. The obesity is rising due to the lack of physical activities, improper or lack of sleep, high calorie diet, and fast food and heredity history of the person. The ideal anti-obesity therapeutics follows mechanisms that regulate energy balance which have substantial built-in-redundancy and overlap with other physiological functions of the body.
In the past decade, numerous anti-obesity therapeutic drugs approved such as Knoll and Acomplia (rimonabant) and few drugs are also removed from the market due to its side effects such as cardiovascular diseases, depression and psychological disorders.
In the current lifestyle, being slim and fit has become the trend. The rising concern of being overweight and obese resulted in the risk of many chronic diseases, cardiovascular diseases and cancer, leads to the need of cure and prevention of obesity which augments the market growth of the anti-obesity therapeutics.
Request Sample PDF Brochure:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-3205
Anti-Obesity Therapeutics Market: Drivers and Restraints
The global anti-obesity therapeutics market is projected to grow at a significant CAGR over a forecast period. The rising prevalence of the obesity due to the rapidly changing lifestyle is the leading factor increasing the demand of the anti-obesity therapeutics and drives the global anti-obesity therapeutics market.
The Increasing consumption of the fast food and lack of exercise in the population leads to the obesity and related disorders, propel the demand of the anti-obesity therapeutics and drives the growth of the global anti-obesity therapeutics market.
The increasing focus and expenditure on research and development activities to enhance the anti-obesity therapeutic effectiveness and to reduce the side effects of the drugs also augment the demand of the anti-obesity therapeutics market.
However, the side effects of the anti-obesity therapeutics such as psychiatric disorder as well as strokes may hamper the demand of the anti-obesity therapeutics and restrain the growth of the global anti-obesity therapeutics market. The negative perception about the anti-obesity therapeutics among the health professionals due to its side effects may hinder the demand of the anti-obesity therapeutics and restrain the growth of the global anti-obesity therapeutics market.
Anti-Obesity Therapeutics Market: Regional Overview
The global anti-obesity therapeutics market is segmented into the seven regions: North America, Latin America, Western Europe, and Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East and Africa (MEA). The North America is dominating and contributed the leading shares to the global anti-obesity therapeutics market in terms of revenue and volume as the one third of the population of North America facing the obesity and related disorders.
The Western Europe is also contributed the significant shares to the global anti-obesity therapeutics market in terms of revenue due to increasing awareness about the obesity and related issues. The APEJ is the most lucrative market for the anti-obesity therapeutics as the rapidly changing lifestyle and eating habits resulted in the obesity and expected to register a moderate growth rate over a forecast period.
The MEA and Latin America are at a nascent stage of the global anti-obesity therapeutics market and anticipated to show a healthy growth in the global anti-obesity therapeutics market over a forecast period. Overall, the global anti-obesity therapeutics market is expected to register a significant CAGR over a forecast period.
Inquire Before Buying Research Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-3205
Anti-Obesity Therapeutics Market: Key Players
The key players of the global anti-obesity therapeutics market are Becton, Dickinson And Company, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Pharmaceutical Ltd., Eli Lilly and Company, GlaxoSmithKline plc., Johnson & Johnson Inc., Medtronic Inc., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies
Ask For Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-3205
ABOUT FUTURE MARKET INSIGHTS, INC.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Enquiries: sales@futuremarketinsights.com